Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Madrigal Pharmaceuticals, Inc. MDGL

Set alert

Price alert · MDGL

All alert types
477.52 USD +46.37 +10.75%

As of Nov 3, 10:01 AM ET

Bid
477.52 × 1
Ask
478.47 × 1
441.52 Day range 482.73
412.35 52-week range 602.83
YTD
-18.00%
1 year
+15.80%
Open
449.32
Prev close
431.16
Mkt cap
11.04B
Vol
241.00K
Avg vol
270.49K
EPS
-12.85
P/E
0.00
Div yield
0.00%
More statistics
Low
441.52
High
482.73
Forward P/E
44.80
Beta
-1.00
Short ratio
7.90
Inst. own
104.52%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
498.66
200-d avg
499.95
1y target
685.22

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 4, 2026Rating: Wolfe Research · Peer Perform → Outperform
  • Sep 23, 2026Rating: Citigroup · — → Buy
  • Nov 3, 2026Earnings: —; estimate -0.86294; surprise —%
Signals (26)
NameDateAgo
MACD: Buy SignalNov 3, 202631 minutes ago
RSI: OversoldOct 28, 20266 days ago
RSI: OversoldOct 23, 20261 week ago
RSI: OversoldOct 8, 20263 weeks ago
SMA: BearishSep 21, 20261 month ago
SMA: BearishSep 21, 20261 month ago
SMA: BullishSep 17, 20261 month ago
SMA: BullishSep 16, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BearishSep 15, 20261 month ago
MACD: Sell SignalSep 15, 20261 month ago
SMA: BullishAug 26, 20262 months ago
SMA: BullishAug 26, 20262 months ago
MACD: Buy SignalAug 26, 20262 months ago
MACD: Sell SignalAug 25, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BullishAug 17, 20262 months ago
MACD: Buy SignalAug 17, 20262 months ago

Newest 20 of 26.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 685.22 +43.5% upside
Target (low)
533.00
Target (mean)
685.22
Target (high)
962.00
Ratings (0m) 19 18 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy15
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 19
  • 1 month ago 19
  • 2 months ago 17

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MDGL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.09-1.38 – -0.56-4.96+78.1%405.12M+41.0%4
Next quarter-0.4225-0.77 – 0.11-2.57+83.6%446.28M+39.0%4
Current year-6.49-7.38 – -4.91-12.73+49.0%1.53B+59.4%4
Next year9.637.01 – 12.84-6.49+248.3%2.12B+38.8%4

Upgrades and downgrades

The latest rating changes

MDGL analyst upgrades and downgrades
DateFirmActionFromTo
Sep 23, 2026CitigroupInitiated—Buy
Aug 4, 2026Wolfe ResearchUpgradePeer PerformOutperform
Aug 3, 2026BarclaysMaintainedOverweightOverweight
Jul 29, 2026Canaccord GenuityMaintainedBuyBuy
Jul 27, 2026Wells FargoInitiated—Overweight
Jun 11, 2026B of A SecuritiesMaintainedNeutralNeutral
May 13, 2026Truist SecuritiesMaintainedBuyBuy
May 7, 2026Canaccord GenuityMaintainedBuyBuy
May 7, 2026Evercore ISI GroupMaintainedOutperformOutperform
May 6, 2026HC Wainwright & Co.ReiteratedBuyBuy
Feb 20, 2026B of A SecuritiesMaintainedNeutralNeutral
Jan 28, 2026BarclaysInitiated—Overweight
Jan 20, 2026CitizensMaintainedMarket OutperformMarket Outperform
Dec 19, 2025Piper SandlerMaintainedOverweightOverweight
Dec 11, 2025B. Riley SecuritiesMaintainedBuyBuy
Nov 21, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 20, 2025OppenheimerMaintainedOutperformOutperform
Nov 19, 2025Truist SecuritiesMaintainedBuyBuy
Nov 13, 2025Canaccord GenuityMaintainedBuyBuy
Nov 11, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 5, 2025Cantor FitzgeraldUpgradeNeutralOverweight
Nov 5, 2025CitizensMaintainedMarket OutperformMarket Outperform
Nov 3, 2025B of A SecuritiesUpgradeUnderperformNeutral
Oct 15, 2025Piper SandlerMaintainedOverweightOverweight
Oct 15, 2025Truist SecuritiesInitiated—Buy
Oct 10, 2025OppenheimerMaintainedOutperformOutperform
Sep 29, 2025B. Riley SecuritiesMaintainedBuyBuy
Sep 12, 2025Canaccord GenuityMaintainedBuyBuy
Aug 26, 2025TD CowenMaintainedBuyBuy
Aug 20, 2025JMP SecuritiesMaintainedMarket OutperformMarket Outperform